BNP Paribas Financial Markets
ALGS icon

BNP Paribas Financial Markets’s Aligos Therapeutics ALGS Stock Holding History

BNP Paribas Financial Markets’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17 Hold
3
– – ﹤0.01% 5858
2026
Q1 		$22 Hold
3
– – ﹤0.01% 5749
2025
Q4 		$28 Hold
3
– – ﹤0.01% 5659
2025
Q3 		$29 Sell
3
-1,813
-100% -$16.6K ﹤0.01% 5489
2025
Q2 		$13.1K Buy
1,816
+1,813
+60,433% +$10.8K ﹤0.01% 4773
2025
Q1 		$25 Hold
3
– – ﹤0.01% 5314
2024
Q4 		$120 Hold
3
– – ﹤0.01% 5269
2024
Q3 		$26 Buy
+3
New +$37 ﹤0.01% 4101

Other funds holding ALGS

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

BNP Paribas Financial Markets's ALGS Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Aligos Therapeutics (ALGS) position steady in Q2 2026 at 3 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #5858.

BNP Paribas Financial Markets first reported a position in ALGS in Q3 2024 and has held it in 8 quarters since. The position peaked at $13.1K in Q2 2025. 19 funds tracked by Wall St. Rank hold ALGS as of Q2 2026.

  • BNP Paribas Financial Markets held 3 shares of Aligos Therapeutics worth $17 as of Q2 2026.
  • BNP Paribas Financial Markets left its Aligos Therapeutics share count unchanged in Q2 2026.
  • Aligos Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5858 holding.
  • BNP Paribas Financial Markets first reported a position in Aligos Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Aligos Therapeutics position peaked at $13.1K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.